Samrat Pharmachem Bilan de santé
Santé financière contrôle des critères 6/6
Samrat Pharmachem has a total shareholder equity of ₹650.0M and total debt of ₹84.5M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are ₹1.2B and ₹567.4M respectively. Samrat Pharmachem's EBIT is ₹36.4M making its interest coverage ratio 5.5. It has cash and short-term investments of ₹97.4M.
Informations clés
13.0%
Ratio d'endettement
₹84.55m
Dette
| Ratio de couverture des intérêts | 5.5x |
| Argent liquide | ₹97.36m |
| Fonds propres | ₹649.97m |
| Total du passif | ₹567.39m |
| Total des actifs | ₹1.22b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: 530125's short term assets (₹1.0B) exceed its short term liabilities (₹564.0M).
Passif à long terme: 530125's short term assets (₹1.0B) exceed its long term liabilities (₹3.4M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 530125 has more cash than its total debt.
Réduire la dette: 530125's debt to equity ratio has reduced from 30.3% to 13% over the past 5 years.
Couverture de la dette: 530125's debt is well covered by operating cash flow (111.3%).
Couverture des intérêts: 530125's interest payments on its debt are well covered by EBIT (5.5x coverage).